renal and visceral disease, late deaths (within two years) are largely attributable to cerebrovascular, and to a lesser extent cardiac, events.2 The addition of cytotoxic agents to corticosteroids may be more efficacious than steroids alone in treatment of PAN4; this approach, or the use of higher dose immunosuppressive treatment, should be considered for patients with PAN who have evidence of cerebrovascular disease. The early recognition and appropriate treatment of PAN significantly improves prognosis;5 our case, and the frequent deaths from cerebrovascular disease in PAN, suggests that cerebral involvement in this condition requires further attention and may merit more aggressive treatment.
Improved renal function indicates a good renovascular response to immunosuppressive treatment. In contrast, there were repeated further neurological events recorded as cerebral infarcts. As far as we know this variable response between the cerebral and renal circulations has not been described previously. IAIN Western blot analysis in the serum and synovialfluid samplesfrom the patients with rheumatoid arthritis positivefor antibody to HTLV-I by particle agglutination method. Odd numbered lanes show the results for HTLV-I IgG antibodies, and even numbered lanes show thatfor HTLV-I IgM antibodies. Lanes I and 2 are negative controls, lanes 3 and 4 positive controls. The samples oflanes 5, 6, 9, 10, 13, 14, 17, 18, 21, 22, 25, and 26 are the serum samples, and those oflanes 7, 8, 11, 12, 15, 16, 19, 20, 23, 24, 27 , and 28 are the synovialfluids ofthe patients.
